Management of colon cancer in patients with cirrhosis: A review

Surgical Oncology

Volumn 24, Issue 3, 2015, Pages 187-193

  Sabbagh, C ^a,b   Cosse, C ^a,b   Chauffert, Bruno ^a,b   Nguyen Khac, E ^a   Joly, Jean Paul ^a   Yzet, Thierry ^a   Regimbeau, J M ^a,b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

Cirrhosis; Colon cancer; Management; Oncological strategy

Indexed keywords

OXALIPLATIN; ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; COCHRANE LIBRARY; COLON CANCER; COLON POLYP; COLON SURGERY; HIGH RISK PATIENT; HUMAN; LAPAROTOMY; LIVER CIRRHOSIS; LIVER METASTASIS; LIVER TOXICITY; MEDLINE; MORBIDITY; PORTAL HYPERTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SURGICAL DRAINAGE; SURVIVAL TIME; COLONIC NEOPLASMS; COMPLICATION; DISEASE MANAGEMENT; MULTIMODALITY CANCER THERAPY; PROGNOSIS;

ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE MANAGEMENT; HUMANS; LIVER CIRRHOSIS; PROGNOSIS;

EID: 84942199640     PISSN: 09607404     EISSN: 18793320     Source Type: Journal    
DOI: 10.1016/j.suronc.2015.06.010     Document Type: Review

References (42)

1. S. Pol, A. Vallet-Pichard, M. Corouge, and V.O. Mallet Hepatitis C: epidemiology, diagnosis, natural history and therapy Contrib. Nephrol. 176 2012 1 9
2. G. Baffy, E.M. Brunt, and S.H. Caldwell Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace J. Hepatol. 56 2012 1384 1391
3. J. Trinchet Critères diagnostiques et bilan initial de la cirrhose non compliquée In Edition 2006 http://www.has-sante.fr
4. S.K. Asrani, and P.S. Kamath Natural history of cirrhosis Curr. Gastroenterol. Rep. 15 2013 308
5. J. Paolino, and R.M. Steinhagen Colorectal surgery in cirrhotic patients ScientificWorldJournal 2014 2014 239293
6. C. Sabbagh, D. Fuks, and J.M. Regimbeau Digestive surgery (except liver surgery) in patients with cirrhosis J. Visc. Surg. 151 2014 203 211
7. A.S. Befeler, D.E. Palmer, M. Hoffman, W. Longo, H. Solomon, and A.M. Di Bisceglie The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome Arch. Surg. 140 2005 650 654 discussion 655
8. C.G. Child, and J.G. Turcotte Surgery and portal hypertension Major Probl. Clin. Surg. 1 1964 1 85
9. F. Pessione, M.J. Ramond, L. Peters, B.N. Pham, P. Batel, B. Rueff, and et al. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence Liver Int. 23 2003 45 53
10. T.A. Wind Ph, and R. Parc La chirurgie colo-rectale chez le cirrhotique Springer-Verlag La chirurgie digestive chez le cirrhotique, Edition 1993
11. M.J. Goldacre, C.J. Wotton, D. Yeates, V. Seagroatt, and J. Collier Liver cirrhosis, other liver diseases, pancreatitis and subsequent cancer: record linkage study Eur. J. Gastroenterol. Hepatol. 20 2008 384 392
12. H. Balshem, M. Helfand, H.J. Schunemann, A.D. Oxman, R. Kunz, J. Brozek, and et al. GRADE guidelines: 3. Rating the quality of evidence J. Clin. Epidemiol. 64 2011 401 406
13. H.T. Sorensen, S. Friis, J.H. Olsen, A.M. Thulstrup, L. Mellemkjaer, M. Linet, and et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark Hepatology 28 1998 921 925
14. L. Serfaty, A. De Leusse, O. Rosmorduc, B. Desaint, J.F. Flejou, O. Chazouilleres, and et al. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study Hepatology 38 2003 203 209
15. E. Dahl, J. Rumessen, and L.L. Gluud Systematic review with meta-analyses of studies on the association between cirrhosis and liver metastases Hepatol. Res. 41 2011 618 625
16. S. Uetsuji, M. Yamamura, K. Yamamichi, Y. Okuda, H. Takada, and K. Hioki Absence of colorectal cancer metastasis to the cirrhotic liver Am. J. Surg. 164 1992 176 177
17. C. Iascone, M. Ruperto, and P. Barillari Occurrence of synchronous colorectal cancer metastasis in the cirrhotic or fatty liver Minerva Chir. 60 2005 185 190
18. S. Naveau, J.C. Chaput, P. Bedossa, T. Poynard, C. Pauphilet, O. Ink, and et al. Cirrhosis as an independent risk factor for colonic adenomas Gut 33 1992 535 540
19. J.W. Jeon, H.P. Shin, J.I. Lee, K.R. Joo, K.M. Pack, J.M. Cha, and et al. The risk of postpolypectomy bleeding during colonoscopy in patients with early liver cirrhosis Surg. Endosc. 26 2012 3258 3263
20. H.S. Kim, T.I. Kim, W.H. Kim, Y.H. Kim, H.J. Kim, S.K. Yang, and et al. Risk factors for immediate postpolypectomy bleeding of the colon: a multicenter study Am. J. Gastroenterol. 101 2006 1333 1341
21. J.L. Martinez, H. Rivas, S. Delgado, A. Castells, J.M. Pique, and A.M. Lacy Laparoscopic-assisted colectomy in patients with liver cirrhosis Surg. Endosc. 18 2004 1071 1074
22. W.S. Cobb, B.T. Heniford, J.M. Burns, A.M. Carbonell, B.D. Matthews, and K.W. Kercher Cirrhosis is not a contraindication to laparoscopic surgery Surg. Endosc. 19 2005 418 423
23. J. Montomoli, R. Erichsen, C.F. Christiansen, S.P. Ulrichsen, L. Pedersen, T. Nilsson, and et al. Liver disease and 30-day mortality after colorectal cancer surgery: a Danish population-based cohort study BMC Gastroenterol. 13 2013 66
24. N.G. Csikesz, L.N. Nguyen, J.F. Tseng, and S.A. Shah Nationwide volume and mortality after elective surgery in cirrhotic patients J. Am. Coll. Surg. 208 2009 96 103
25. C.S. Lin, S.Y. Lin, C.C. Chang, H.H. Wang, C.C. Liao, and T.L. Chen Postoperative adverse outcomes after non-hepatic surgery in patients with liver cirrhosis Br. J. Surg. 100 2013 1784 1790
26. K. Meunier, S. Mucci, V. Quentin, R. Azoulay, J.P. Arnaud, and A. Hamy Colorectal surgery in cirrhotic patients: assessment of operative morbidity and mortality Dis. Colon Rectum 51 2008 1225 1231
27. A.A. Ghaferi, A.K. Mathur, C.J. Sonnenday, and J.B. Dimick Adverse outcomes in patients with chronic liver disease undergoing colorectal surgery Ann. Surg. 252 2010 345 350
28. G.C. Nguyen, A.J. Correia, and P.J. Thuluvath The impact of cirrhosis and portal hypertension on mortality following colorectal surgery: a nationwide, population-based study Dis. Colon Rectum 52 2009 1367 1374
29. T.L. Hedrick, B.R. Swenson, and C.M. Friel Model for end-stage liver disease (MELD) in predicting postoperative mortality of patients undergoing colorectal surgery Am. Surg. 79 2013 347 352
30. S.W. Leichtle, N.J. Mouawad, K.B. Welch, R.M. Lampman, and R.K. Cleary Risk factors for anastomotic leakage after colectomy Dis. Colon Rectum 55 2012 569 575
31. L.T. Sorensen, T. Jorgensen, L.T. Kirkeby, J. Skovdal, B. Vennits, and P. Wille-Jorgensen Smoking and alcohol abuse are major risk factors for anastomotic leakage in colorectal surgery Br. J. Surg. 86 1999 927 931
32. D. Azoulay, F. Buabse, I. Damiano, A. Smail, P. Ichai, M. Dannaoui, and et al. Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension J. Am. Coll. Surg. 193 2001 46 51
33. E. Vinet, P. Perreault, L. Bouchard, D. Bernard, R. Wassef, C. Richard, and et al. Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study Can. J. Gastroenterol. 20 2006 401 404
34. J.H. Slade, M.L. Alattar, D.R. Fogelman, M.J. Overman, A. Agarwal, D.M. Maru, and et al. Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury Clin. Colorectal Cancer 8 2009 225 230
35. E. Nguyen-Khac, C. Lobry, D. Chatelain, D. Fuks, J.P. Joly, M. Brevet, and et al. A Reappraisal of chemotherapy-induced liver injury in colorectal liver metastases before the era of antiangiogenics Int. J. Hepatol. 2013 2013 314868
36. K.M. Madbouly, A.M. Hussein, and A. Zeid Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis? Dis. Colon Rectum 56 2013 577 585
37. P. Gervaz, R. Pak-art, S. Nivatvongs, B.G. Wolff, D. Larson, and S. Ringel Colorectal adenocarcinoma in cirrhotic patients J. Am. Coll. Surg. 196 2003 874 879
38. F. Gundling, H. Seidl, F. Schmidtler, N. Loffler, I. Strassen, P. Wolf, and et al. Nonhepatic cancer in liver cirrhosis: a retrospective study of prevalence, complication rate after specific oncological treatment, follow-up and prognostic predictors of outcome in 354 patients with cirrhosis Anticancer Res. 31 2011 2931 2938
39. T. Andre, C. Boni, L. Mounedji-Boudiaf, M. Navarro, J. Tabernero, T. Hickish, and et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N. Engl. J. Med. 350 2004 2343 2351
40. R.N. Garrison, H.M. Cryer, D.A. Howard, and H.C. Polk Jr. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis Ann. Surg. 199 1984 648 655
41. A.M. Metcalf, R.R. Dozois, B.G. Wolff, and R.W. Beart Jr. The surgical risk of colectomy in patients with cirrhosis Dis. Colon Rectum 30 1987 529 531
42. A.M. Bouvier, L. Remontet, G. Hedelin, G. Launoy, V. Jooste, P. Grosclaude, and et al. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis Cancer 115 2009 4616 4624